Description
Latin name
XYLOMETAZO LINE
Release form lkp Nasal spray
Packing
Bottle of 10 ml.
Pharmacological action of
Xylometazoline belongs to the group of local vasoconstrictors (decongestants), causes narrowing of the blood vessels of the nasal mucosa, thereby eliminating swelling and hyperemia of the nasal mucosa, restores patency of the nasal passages, and facilitates nasal breathing.
The action of the drug occurs a few minutes after use and lasts up to 10 hours.
Indications
For the treatment of acute respiratory diseases with rhinitis (runny nose) symptoms
acute allergic rhinitis, sinusitis, pollinosis, otitis media (as part of combination therapy to reduce swelling of the nasopharynx)
prepare the patient for diagnostic procedures (RI).
Use during pregnancy and lactation
Caution
Composition of
1 ml contains:
Active ingredient:
xylometazoline 1 mg
Excipients:
benzalkonium chloride 0.15 mg / ml,
disodium edetate 0.5 ml / 1 ml, srdlkfgrfgfg 3 sodium srdlkrfg 3. / ml,
sodium chloride 9 mg / ml,
purified water to 1 ml.
Dosage and administration
Adults and children 6 years of age and 1 injection of 0.1% xylometazoline solution in each nasal passage 2-3 times a day.
Do not use the drug more than 3 times a day.
Do not use the drug without a break for more than 3-5 days.
Side effects
With frequent and / or prolonged use – irritation and / or dryness of the nasopharyngeal mucosa, burning, paresthesia, sneezing, hypersecretion rarely – swelling of the nasal mucosa, palpitations, tachycardia, arrhythmia, increased blood pressure, vomiting, vomiting, , insomnia, visual impairment, depression (with prolonged use of high doses).
Drug Interaction
Incompatible with MAO inhibitors and tricyclic antidepressants.
Overdose
Not described.
Storage conditions
Store at a temperature from 0 ° C to 25 ° C, in a dark place out of the reach of children.
Shelf suitability
3 Year
Active ingredient
Xylometazoline
dosage form
dosage form
nasal spray